Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-606-6856
Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Harris specializes in caring for people with gastrointestinal malignancies including hepatobiliary and pancreatic cancer.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2007 - 2009- University of WashingtonResidency, Internal Medicine, 2001 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
WA State Medical License 2001 - 2027
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma.Anthony B El-Khoueiry, Richard D Kim, William P Harris, Max W Sung, Dirk Waldschmidt
Hepatology. 2025-11-10 - Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.Gentry G King, Kelsey K Baker, Andrew L Coveler, William P Harris, Stacey A Cohen
Cancers. 2025-05-30 - 2 citationsOptimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety anal...Riad Salem, Etienne Garin, Eveline Boucher, Kirk Fowers, Marnix Lam
The Oncologist. 2024-08-05
Press Mentions
A Daughter Gives Her Mom the Gift of ‘Renewed Time’ by Donating Part of Her Liver in a Rare Transplant at UWFebruary 4th, 2021
SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 31st, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
